Harsh Desai MD (@harsh_desai_1) 's Twitter Profile
Harsh Desai MD

@harsh_desai_1

@UCIrvine Alum | @UToledoMed Alum | #Neurology Resident @neuroUCMC | Love to #eat and enjoy #nature | #mavicmini pilot | Married to @KavyaPaiMD | He/Him

ID: 1279014192109027328

calendar_today03-07-2020 11:28:52

54 Tweet

262 Takipçi

254 Takip Edilen

Harsh Desai MD (@harsh_desai_1) 's Twitter Profile Photo

When you finish interview season and need a new hobby, I recommend a #Hogwarts 3D puzzle! Castle ✅ Next up, the observatory! How are other people on #NeuroTwitterNetwork trying to relax?? P.S. Yes that is a #Fortnite Llama in the background.

When you finish interview season and need a new hobby,  I recommend a #Hogwarts 3D puzzle!
 Castle ✅
Next up, the observatory!

How are other people on #NeuroTwitterNetwork trying to relax??

P.S. Yes that is a #Fortnite Llama in the background.
Tareq Kass-Hout (@tareqkass) 's Twitter Profile Photo

Step by step illustration of accessing intracranial vessels with large bore access Zoom RDL catheter directly through radial artery drive.google.com/file/d/1YusYf0… Many thanks to our great team @sonamthind Harsh Desai MD Sachin A. Kothari Rami Z. Morsi, MD

Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile Photo

🎉Publication alert 🎉 Excited to share with you all results from our latest article, titled "Intravenous cangrelor use for neuroendovascular procedures: a two-center experience and updated systematic review" in Frontiers - Neurology! doi.org/10.3389/fneur.… Tweetorial below (1/17)

🎉Publication alert 🎉 Excited to share with you all results from our latest article, titled "Intravenous cangrelor use for neuroendovascular procedures: a two-center experience and updated systematic review" in <a href="/FrontNeurol/">Frontiers - Neurology</a>! doi.org/10.3389/fneur.… Tweetorial below (1/17)
Tareq Kass-Hout (@tareqkass) 's Twitter Profile Photo

Join UChicago Medicine's NeuroEndovascular Surgery e-Fellowship! Elevate your neurointerventional skills with 100+ live & recorded cases from world-class experts. Flexible online format. Earn CME. Apply now: cme.uchicago.edu/NSF25 #neurosurgery #medtwitter"

UChicago Neurology Residency (@neuroucmc) 's Twitter Profile Photo

We are all so excited to be hosting our annual virtual open house on September 12th at 7PM CST! Be on the lookout for another post later this week with registration details! Bring all of your questions! 🧐☺️ @nmatch2025 UChicagoNeuro

We are all so excited to be hosting our annual virtual open house on September 12th at 7PM CST! Be on the lookout for another post later this week with registration details! Bring all of your questions! 🧐☺️
@nmatch2025 <a href="/UChicago_Neuro/">UChicagoNeuro</a>
UChicago Neurology Residency (@neuroucmc) 's Twitter Profile Photo

Join us next Thursday, September 12th for our Virtual Open House! Register using the QR code in the post! #VirtualOpenHouse #Neurology @NMatch2025

Join us next Thursday, September 12th for our Virtual Open House! Register using the QR code in the post! #VirtualOpenHouse #Neurology @NMatch2025
JNIS (@jnis_bmj) 's Twitter Profile Photo

🔥 off the press! Work from Sachin A. Kothari Rami Z. Morsi, MD Harsh Desai MD demonstrates that pre-hospital stroke screening forms perform similarly when used for LVOs and MeVOs-- though LAMS is the most discriminative. bit.ly/40zPHsi

🔥 off the press! Work from <a href="/sachinkothari94/">Sachin A. Kothari</a> <a href="/DrRamiMorsi/">Rami Z. Morsi, MD</a> <a href="/Harsh_Desai_1/">Harsh Desai MD</a> demonstrates that pre-hospital stroke screening forms perform similarly when used for LVOs and MeVOs-- though LAMS is the most discriminative. bit.ly/40zPHsi
Rami Z. Morsi, MD (@drramimorsi) 's Twitter Profile Photo

🧵1/ 🚨 New study drop! We're excited to share our work comparing reduced-dose ticagrelor, full-dose ticagrelor, and clopidogrel for secondary prevention after acute stroke/TIA. Big thanks to Harsh Desai MD, Elena Badillo Goicoechea, and the entire team! sciencedirect.com/science/articl…

🧵1/ 🚨 New study drop! We're excited to share our work comparing reduced-dose ticagrelor, full-dose ticagrelor, and clopidogrel for secondary prevention after acute stroke/TIA. Big thanks to <a href="/Harsh_Desai_1/">Harsh Desai MD</a>, Elena Badillo Goicoechea, and the entire team! sciencedirect.com/science/articl…